N-[N-[3-(3-methoxy-4-hydroxyphenyl)propyl]-L--aspartyl]-L-phenylalanine 1-methyl ester is prepared by a process comprising:

    • subjecting Aspartame and 3-(3-methoxy-4-hydroxyphenyl)propionaldehyde or derivatives thereof to reductive alkylation in a solvent to produce N-[N-[3-(3-methoxy-4-hydroxyphenyl)propyl]-L--aspartyl]-L-phenylalanine 1-methyl ester; and
    • crystallizing said compound.

    		•
     
    Web www.patentalert.com

    < Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)

    < Benzimidazolidinone derivatives

    > Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them

    > Polymorphic forms of sertraline hydrochloride
    ~ 00205